Insomnia Brands

Takeda's selective melatonin MT1 and MT2 receptor agonist (ramelteon) for insomnia, FDA approved July 22, 2005, as the first prescription sleep aid with no abuse potential and no DEA scheduling, indicated for sleep-onset insomnia in adults, available as an 8 mg film-coated tablet taken 30 minutes before bedtime.